Table 4.
Model | SSRI/SNRI | Benzodiazepine | Atypical antipsychotics | |||
---|---|---|---|---|---|---|
OR (95 % CI)* c statistic | OR (95 % CI) c statistic | OR (95 % CI) c statistic | ||||
Unadjusted | 1.37 | 0.511 | 1.47 | 0.514 | 1.31 | 0.510 |
(1.34, 1.40) | (1.43, 1.50) | (1.28, 1.35) | ||||
Demographics only | 1.34 | 0.567 | 1.63 | 0.608 | 1.08 | 0.605 |
(1.31, 1.37) | (1.60, 1.67) | (1.05, 1.10) | ||||
Comorbidity only | 1.13 | 0.630 | 1.27 | 0.590 | 1.25 | 0.607 |
(1.10, 1.15) | (1.24, 1.30) | (1.22, 1.28) | ||||
Demographics and comorbidity | 1.15 | 0.658 | 1.47 | 0.653 | 1.08 | 0.652 |
(1.12, 1.18) | (1.44, 1.51) | (1.05, 1.11) |
*Odds ratio and 95 % confidence interval for the likelihood of receiving medication in women compared to men